These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7803373)

  • 1. Cognitive decline in schizophrenic patients: relationship to other symptoms.
    Dalby JT; Williams R; Dickson R; Yuen O
    J Psychiatry Neurosci; 1994 Nov; 19(5):381-2. PubMed ID: 7803373
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia.
    Goldstein G; Shemansky WJ; Allen DN
    Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia: measurements of psychopathology.
    Lindenmayer JP; Harvey PD; Khan A; Kirkpatrick B
    Psychiatr Clin North Am; 2007 Sep; 30(3):339-63. PubMed ID: 17720027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premorbid IQ and schizophrenia. Increasing cognitive reduction by episodes.
    Eberhard J; Riley F; Levander S
    Eur Arch Psychiatry Clin Neurosci; 2003 Apr; 253(2):84-8. PubMed ID: 12799746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining a cognitive function decrement in schizophrenia.
    Keefe RS; Eesley CE; Poe MP
    Biol Psychiatry; 2005 Mar; 57(6):688-91. PubMed ID: 15780858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia.
    Torres IJ; Keedy S; Marlow-O'Connor M; Beenken B; Goldman MB
    Neuropsychology; 2009 May; 23(3):307-14. PubMed ID: 19413445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive deficit and schizophrenia].
    Torres A; Méndez L; Olivares JM; Vaamonde A
    Actas Esp Psiquiatr; 2001; 29(1):1-9. PubMed ID: 11333512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does operational diagnosis of schizophrenia significantly impact intellectual deficits in psychotic disorders?
    Kitamura H; Shioiri T; Itoh M; Sato Y; Shichiri K; Someya T
    J Intellect Disabil Res; 2007 Oct; 51(Pt 10):812-20. PubMed ID: 17803499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained and selective attention in schizophrenia.
    Green MF; Nuechterlein KH; Gaier DJ
    Prog Exp Pers Psychopathol Res; 1992; 15():290-313. PubMed ID: 1343109
    [No Abstract]   [Full Text] [Related]  

  • 16. Identical neural risk factors predict cognitive deficit in dyslexia and schizophrenia.
    Leonard CM; Kuldau JM; Maron L; Ricciuti N; Mahoney B; Bengtson M; DeBose C
    Neuropsychology; 2008 Mar; 22(2):147-58. PubMed ID: 18331156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenic patients treated with electroconvulsive therapy: their demographic, clinical and cognitive features.
    Gureje O
    East Afr Med J; 1988 Jun; 65(6):379-86. PubMed ID: 3181059
    [No Abstract]   [Full Text] [Related]  

  • 18. Autonoetic awareness associated with the projection of the self into the future: an investigation in schizophrenia.
    de Oliveira H; Cuervo-Lombard C; Salamé P; Danion JM
    Psychiatry Res; 2009 Aug; 169(1):86-7. PubMed ID: 19616311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of schizophrenia from cognitive disorders in AD/HD].
    Niwa S; Takanashi S; Itagaki T; Miyashita H
    Seishin Shinkeigaku Zasshi; 2005; 107(7):718-28. PubMed ID: 16250123
    [No Abstract]   [Full Text] [Related]  

  • 20. Symptomatological and cognitive predictors of insight in chronic schizophrenia.
    Nakano H; Terao T; Iwata N; Hasako R; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):65-72. PubMed ID: 15261706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.